BioXcel Therapeutics Inc.

1.87
0.02 (1.08%)
At close: Apr 25, 2025, 3:59 PM
1.90
1.64%
Pre-market: Apr 28, 2025, 09:17 AM EDT

BioXcel Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
2.27M 1.38M 375K n/a n/a n/a n/a n/a n/a
n/a 1.26M 20K 297K 188K 156K 17K 1K n/a
2.27M 120K 355K -297K -188K -156K -17K -1K n/a
-67.25M -171.78M -159.65M -106.94M -82.3M -33.6M -19.96M -4.54M -2.12M
2.6M 5.65M 2.53M 4K 155K 633K n/a n/a n/a
-59.6M -179.05M -165.76M -106.93M -82.17M -32.97M -19.27M -4.54M -2.12M
-59.6M -179.05M -171.85M -106.63M -82.01M -32.34M -19.27M -4.54M -2.12M
34.49M 83.41M 68.76M 54.23M 24.3M 7.8M 5.4M 1.85M 721K
30.43M 84.33M 91.24M 52.71M 57.99M 25.8M 14.56M 2.69M 1.4M
4.58M 4.16M -427K n/a n/a n/a n/a n/a n/a
69.51M 171.9M 160M 106.94M 82.3M 33.6M 19.96M 4.54M 2.12M
15.13M 13.31M 8.21M 40K 27K n/a n/a 2K n/a
1.39M 19.9M 13.01M n/a n/a n/a n/a n/a n/a
69.51M 173.16M 160.02M 106.94M 82.3M 33.6M 19.96M 4.54M 2.12M
n/a n/a 6.09M -301K -161K -633K 692K n/a -2.12M
2.54M 29.13M 28.02M 26.37M 21.68M 16.29M 14.57M 15.19M 15.65M
2.54M 29.13M 28.02M 26.37M 21.68M 16.29M 14.57M 15.19M 15.65M
-23.51 -6.15 -6.13 -4.04 -3.78 -1.99 -1.32 -0.3 -0.14
-23.51 -6.15 -6.13 -4.04 -3.78 -1.99 -1.32 -0.3 -0.14
-44.16M -165.42M -157.38M -107M -81.98M -32.81M -19.25M -4.54M n/a
-44.47M -165.74M -157.54M -107.29M -82.17M -32.97M -19.27M -4.54M -2.12M
309K 318K 327K 297K 188K 156K 17K 1K 2.12M